| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/27/2006 | US7067629 Sodium channel in dorsal root ganglia |
| 06/27/2006 | US7067627 Schizophrenia associated genes, proteins and biallelic markers |
| 06/27/2006 | US7067626 Human ion channel proteins |
| 06/27/2006 | US7067496 Transplanting into dermis, least one hair follicle that has been modified ex vivo to contain nucleic acid molecule to introduce nucleic acid molecule into mammal |
| 06/27/2006 | US7067484 AL-1 neurotrophic factor treatments |
| 06/27/2006 | US7067318 Methods for transfecting T cells |
| 06/27/2006 | US7067317 Wound healing agent |
| 06/27/2006 | US7067316 culturing in the absence of exogenously added hematopoietic growth factors; three-dimensional, solid, porous biomatrix supports high level transduction and allows for expansion of progenitor cell numbers and/or functionality; gene transfer |
| 06/27/2006 | US7067315 Parasiticides; immunoassays; microbiocides |
| 06/27/2006 | US7067314 Monoclonal antibody, its immunoreactive fragment and hybridoma |
| 06/27/2006 | US7067313 Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 06/27/2006 | US7067312 PN7718 nucleic acids and use thereof |
| 06/27/2006 | US7067309 Used for the transfer and expression of exogenous nucleotide sequences in a host cell or organism; gene therapy |
| 06/27/2006 | US7067308 Vector for genetically modifying non-human animals |
| 06/27/2006 | US7067306 Device containing cytophilic islands that adhere cells separated by cytophobic regions |
| 06/27/2006 | US7067296 Enzymatic polypeptide for use in the treatment of pain, inflammation, arthritis, cancer and alzheimer's disease |
| 06/27/2006 | US7067295 Glucose dehydrogenase |
| 06/27/2006 | US7067285 Desaturase genes and uses thereof |
| 06/27/2006 | US7067281 Mammalian IAP gene family, primers, probes and detection methods |
| 06/27/2006 | US7067278 capable of hybridizing and which encodes a pigment protein capable of emitting fluorescence upon irradiation; tissue marker, fluorescent marker or general dyestuff |
| 06/27/2006 | US7067265 Transgenic cells coding membrane protein which controls intracellular hydrogen ion concentration for identifying modulators for treatment of diabetes |
| 06/27/2006 | US7067262 Determination binding of gabapentin to cells |
| 06/27/2006 | US7067259 Multidrug resistance proteins in Drosophila and Anopheles |
| 06/27/2006 | US7067130 Genetic engineering; polypeptide; cancer diagnosis |
| 06/27/2006 | US7067127 Amino and nucleotide sequences; isolated, hybrid nucleic acid; purification of enzyme |
| 06/27/2006 | US7067126 Synthase enzymes having chemokine, angiogenic or angiostsatic activity, used for medical diagnosis and prognosis |
| 06/27/2006 | US7067121 Grafting heart tissue; closure of heart defect |
| 06/27/2006 | US7067120 Cytokine gene modified antigen-presenting cell/tumor cell conjugate, its preparation and use |
| 06/27/2006 | US7067118 Methods of using mutant flt3-ligand polypeptides to induce cellular expansion |
| 06/27/2006 | CA2426283C Method for direct rescue and amplification of integrated viruses from cellular dna of tissues |
| 06/27/2006 | CA2283740C Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
| 06/27/2006 | CA2263729C Process for producing mammals with defined genetic properties |
| 06/22/2006 | WO2006066229A2 Elicitation of antibodies to self peptides by immunization with dendritic cells |
| 06/22/2006 | WO2006066089A1 Humanized amyloid beta antibodies for use in improving cognition |
| 06/22/2006 | WO2006065975A2 Methods of treating ankylosing spondylitis using anti-tnf antibodies and peptides of human tumor necrosis factor |
| 06/22/2006 | WO2006065933A2 Oxygen-controlled environment for cell- and tissue culture |
| 06/22/2006 | WO2006065599A1 Method of using extracts of epimedium species |
| 06/22/2006 | WO2006065495A2 Methods of using il-21 for adoptive immunotherapy and identification of tumor antigens |
| 06/22/2006 | WO2006065103A1 Recombiant vector containing mj1 gene and method of site-specific integration using the same |
| 06/22/2006 | WO2006064983A1 Monoclonal antibody specific human embryonic stem cell |
| 06/22/2006 | WO2006064813A1 Nucleic acid construct and method of transferring mutation into target region by using the same |
| 06/22/2006 | WO2006064721A1 Active form of subtilisin at low temperature |
| 06/22/2006 | WO2006064504A2 Production from blood of cells of neural lineage |
| 06/22/2006 | WO2006064501A2 Regulating stem cells |
| 06/22/2006 | WO2006064020A1 Peptide fractions promoting growth and synthesis of desired product(s) into cell and/or tissue culture |
| 06/22/2006 | WO2006064007A1 Transgenic animal models for neurodevelopmental disorders |
| 06/22/2006 | WO2006063800A1 Cloning of honey bee allergen |
| 06/22/2006 | WO2006042158A3 Methods and compositions for improving recombinant protein production |
| 06/22/2006 | WO2006038129A3 Hepatitis c virus replication system |
| 06/22/2006 | WO2006034832A3 Use of igfbp-2 in senescence diseases and for the maintenance of organ functions |
| 06/22/2006 | WO2006017370A3 Medium for growing human embryonic stem cells |
| 06/22/2006 | WO2006015853A3 Use of pax4 in pancreatic cell proliferation |
| 06/22/2006 | WO2006014678A3 Compositions and methods of using angiopoietin-like 4 protein |
| 06/22/2006 | WO2006011061A3 Isolated muscle satellite cells, use thereof in muscle tissue repair and method for isolating said muscle satellite cells |
| 06/22/2006 | WO2006010600A3 Stem cells obtained from pulp of deciduous or permanent teeth and of dental germ, able to produce human bone tissue |
| 06/22/2006 | WO2005115130A3 Transgenic ficus, method for producing same and use thereof |
| 06/22/2006 | WO2005113005A3 Transcutaneous and/or transdermal transport of materials |
| 06/22/2006 | WO2005110481A3 Prolongation of survival of an allograft by inhibiting complement activity |
| 06/22/2006 | WO2005085422A9 Adult stem cells and uses thereof |
| 06/22/2006 | WO2005081905A3 Systems and methods for clonal expression in plants |
| 06/22/2006 | WO2005065242A3 Method of treating cancer using platelet releasate |
| 06/22/2006 | WO2005047466A3 Apparatus and method for tissue engineering |
| 06/22/2006 | WO2005042703A3 Placental stem cells and uses thereof |
| 06/22/2006 | WO2004052276A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 06/22/2006 | WO2003102130A3 A human cell assay to determine effect of sample compounds on col2 enhancer expression |
| 06/22/2006 | US20060137044 Multibranching watermelon plant and method of producing |
| 06/22/2006 | US20060137042 Process for the production of fine chemicals |
| 06/22/2006 | US20060137038 Thermotolerant phytase for animal feed |
| 06/22/2006 | US20060137037 Inbred maize line 291B |
| 06/22/2006 | US20060137036 Modified plants |
| 06/22/2006 | US20060137035 Controlling |
| 06/22/2006 | US20060137033 Cytokinin-sensing histidine kinases and methods of use |
| 06/22/2006 | US20060137032 Plant alpha farnesene synthase and polynucleotides encoding same |
| 06/22/2006 | US20060137031 Transgenic mice containing retinoid X receptor interacting protein gene disruptions |
| 06/22/2006 | US20060136182 Three dimensional construct for the design and fabrication of physiological fluidic networks |
| 06/22/2006 | US20060135921 Porous particulate collagen sponges |
| 06/22/2006 | US20060135749 Cd47 partal peptdie and anti-shps-1 monoclonal antibody |
| 06/22/2006 | US20060135474 Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B |
| 06/22/2006 | US20060135456 Methods and compositions for RNA interference |
| 06/22/2006 | US20060135445 Breast cancer-resistant protein inhibitor |
| 06/22/2006 | US20060135419 Proteins involved in the regulation of energy homeostasis |
| 06/22/2006 | US20060135415 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/22/2006 | US20060135388 EGVII endoglucanase and nucleic acids encoding the same |
| 06/22/2006 | US20060134791 Masked targeted expression cassette which expresses a gene product only in the presence of target molecule; neoplasm |
| 06/22/2006 | US20060134789 Methods and products for biasing cellular development |
| 06/22/2006 | US20060134788 Recombinant vector containing MJ1 gene and method of site-specific integration using the same |
| 06/22/2006 | US20060134785 Nanoparticles for the administration of active ingredients, method of producing said particles and composition containing same |
| 06/22/2006 | US20060134784 Methods and compositions for the growth and maintenance of stem cells |
| 06/22/2006 | US20060134783 Methods of expanding myeloid cell populations and uses thereof |
| 06/22/2006 | US20060134782 Differentiated cells suitable for human therapy |
| 06/22/2006 | US20060134781 Three-dimensional cell culture system |
| 06/22/2006 | US20060134780 For producing high affinity, fully human antibodies of a desired isotype in response to immunization with any virtually any desired antigen |
| 06/22/2006 | US20060134779 Modulation of cell intrinsic strain to control cell modulus, matrix synthesis, secretion, organization, material properties and remodeling of tissue engineered constructs |
| 06/22/2006 | US20060134755 IL-17 homologous polypeptides and therapeutic uses thereof |
| 06/22/2006 | US20060134749 Protease, DNA encoding the same, and method for manufacturing protease |
| 06/22/2006 | US20060134743 Vectors and methods for enhanced cell longevity and protein expression |
| 06/22/2006 | US20060134741 Composition and methods relating to SENP1-a sentrin-specific protease |
| 06/22/2006 | US20060134738 Gene expression inducing fusion protein and method for controlling gene expression Induction |
| 06/22/2006 | US20060134733 Production of functional proteins: balance of shear stress and gravity |
| 06/22/2006 | US20060134706 Atopic dermatitis inducer |